The Moroccan Medicines and Health Products Agency (AMMPS) has ordered a recall of a batch of CUROSURF 120 mg, a medication used to treat respiratory problems in newborns, after detecting a potential risk of microbial contamination. The post Morocco Recalls Newborn Medication Over Microbial Safety Concern appeared first on Morocco World News .